347 related articles for article (PubMed ID: 20434545)
1. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
Kortekaas J; de Boer SM; Kant J; Vloet RP; Antonis AF; Moormann RJ
Vaccine; 2010 Jun; 28(27):4394-401. PubMed ID: 20434545
[TBL] [Abstract][Full Text] [Related]
2. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of three candidate Rift Valley fever vaccines in sheep.
Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
[TBL] [Abstract][Full Text] [Related]
4. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.
de Boer SM; Kortekaas J; Antonis AF; Kant J; van Oploo JL; Rottier PJ; Moormann RJ; Bosch BJ
Vaccine; 2010 Mar; 28(11):2330-9. PubMed ID: 20056185
[TBL] [Abstract][Full Text] [Related]
5. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
[TBL] [Abstract][Full Text] [Related]
6. Parenteral vaccination of mammalian livestock with Newcastle disease virus-based vector vaccines offers optimal efficacy and safety.
Harmsen MM; Antonis AF; Moormann RJ; Kortekaas J
Bioeng Bugs; 2011; 2(1):58-62. PubMed ID: 21636990
[TBL] [Abstract][Full Text] [Related]
7. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
Boshra H; Lorenzo G; Rodriguez F; Brun A
Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus.
Kortekaas J; Dekker A; de Boer SM; Weerdmeester K; Vloet RP; de Wit AA; Peeters BP; Moormann RJ
Vaccine; 2010 Mar; 28(11):2271-6. PubMed ID: 20079874
[TBL] [Abstract][Full Text] [Related]
9. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
[TBL] [Abstract][Full Text] [Related]
10. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
[TBL] [Abstract][Full Text] [Related]
12. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
[TBL] [Abstract][Full Text] [Related]
13. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.
Wallace DB; Ellis CE; Espach A; Smith SJ; Greyling RR; Viljoen GJ
Vaccine; 2006 Nov; 24(49-50):7181-9. PubMed ID: 16870311
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
15. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
[TBL] [Abstract][Full Text] [Related]
16. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.
Faburay B; Wilson WC; Gaudreault NN; Davis AS; Shivanna V; Bawa B; Sunwoo SY; Ma W; Drolet BS; Morozov I; McVey DS; Richt JA
Sci Rep; 2016 Jun; 6():27719. PubMed ID: 27296136
[TBL] [Abstract][Full Text] [Related]
17. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
[TBL] [Abstract][Full Text] [Related]
18. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
Lorenzo G; Martín-Folgar R; Rodríguez F; Brun A
Vaccine; 2008 Sep; 26(41):5255-62. PubMed ID: 18682268
[TBL] [Abstract][Full Text] [Related]
19. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
Faburay B; Lebedev M; McVey DS; Wilson W; Morozov I; Young A; Richt JA
Vector Borne Zoonotic Dis; 2014 Oct; 14(10):746-56. PubMed ID: 25325319
[TBL] [Abstract][Full Text] [Related]
20. One Health approach to Rift Valley fever vaccine development.
Kortekaas J
Antiviral Res; 2014 Jun; 106():24-32. PubMed ID: 24681125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]